DIABETIC PERIPHERAL NEUROPATHIC PAIN
Clinical trials for DIABETIC PERIPHERAL NEUROPATHIC PAIN explained in plain language.
Never miss a new study
Get alerted when new DIABETIC PERIPHERAL NEUROPATHIC PAIN trials appear
Sign up with your email to follow new studies for DIABETIC PERIPHERAL NEUROPATHIC PAIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could ease diabetic nerve pain without opioids
Symptom relief Recruiting nowThis study tests a new medicine called suzetrigine for people with diabetes who have long-term nerve pain in their legs. About 734 adults will take either the drug or a placebo for 12 weeks to see if it reduces daily pain. The goal is to find a safe, non-opioid option for this co…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated May 26, 2026 05:57 UTC
-
New hope for diabetic nerve pain: experimental drug HRS-2129 enters human trials
Symptom relief Recruiting nowThis study tests a new drug called HRS-2129 to see if it can safely reduce nerve pain caused by diabetes. About 168 adults with diabetic nerve pain will receive either HRS-2129, a placebo (dummy pill), or an approved pain drug (pregabalin) for comparison. The main goal is to meas…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 05:51 UTC
-
New pill aims to ease diabetic nerve pain in major trial
Symptom relief Recruiting nowThis study tests an oral medication called VX-993 for people with diabetic peripheral neuropathy, a common complication of diabetes that causes pain in the legs and feet. About 300 adults with type 1 or type 2 diabetes will receive different doses of VX-993 or an active comparato…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated May 22, 2026 13:51 UTC
-
New pill aims to ease burning nerve pain in diabetes patients
Symptom relief Recruiting nowThis study tests a new medicine called suzetrigine for people with nerve pain from diabetes. About 1,100 adults will receive either the study drug, a placebo, or an active comparator to see if it safely reduces pain. The main goal is to measure pain relief after 12 weeks.
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated May 19, 2026 12:00 UTC
-
New hope for diabetic nerve pain: experimental drug enters phase 2 trial
Symptom relief Recruiting nowThis study tests a new medicine called LY4065967 to see if it safely reduces nerve pain in people with diabetes. About 150 adults with diabetic nerve pain in their legs for at least 6 months will receive either the study drug or a placebo. The main goal is to measure changes in a…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated May 18, 2026 12:10 UTC